Table of Contents

Select this article
- J C Lawrence, Jr and
- P J Roach
New insights into the role and mechanism of glycogen synthase activation by insulin.
Diabetes April 1997 46:541-547; doi:10.2337/diabetes.46.4.541
- Abstract
Select this article
- J M Radziuk,
- J C Davies,
- W S Pye,
- J E Shields,
- R D DiMarchi,
- and R E Chance
Bioavailability and bioeffectiveness of subcutaneous human insulin and two of its analogs--LysB28ProB29-human insulin and AspB10LysB28ProB29-human insulin--assessed in a conscious pig model.
Diabetes April 1997 46:548-556; doi:10.2337/diabetes.46.4.548
- Abstract
Select this article
- W Karges,
- D Hammond-McKibben,
- R K Cheung,
- M Visconti,
- N Shibuya,
- D Kemp,
- and H M Dosch
Immunological aspects of nutritional diabetes prevention in NOD mice: a pilot study for the cow's milk-based IDDM prevention trial.
Diabetes April 1997 46:557-564; doi:10.2337/diabetes.46.4.557
- Abstract
Select this article
- U Wiest-Ladenburger,
- R Hartmann,
- U Hartmann,
- K Berling,
- B O Böhm,
- and W Richter
Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test.
Diabetes April 1997 46:565-571; doi:10.2337/diabetes.46.4.565
- Abstract
Select this article
- A G Baxter,
- S J Kinder,
- K J Hammond,
- R Scollay,
- and D I Godfrey
Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice.
Diabetes April 1997 46:572-582; doi:10.2337/diabetes.46.4.572
- Abstract
Select this article
- J Paronen,
- P Klemetti,
- J M Kantele,
- E Savilahti,
- J Perheentupa,
- H K Akerblom,
- and O Vaarala
Glutamate decarboxylase-reactive peripheral blood lymphocytes from patients with IDDM express gut-specific homing receptor alpha4beta7-integrin.
Diabetes April 1997 46:583-588; doi:10.2337/diabetes.46.4.583
- Abstract
Select this article
- F W Scott,
- H E Cloutier,
- R Kleemann,
- U Wöerz-Pagenstert,
- P Rowsell,
- H W Modler,
- and H Kolb
Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats: dose, timing, early effect on islet area, and switch in infiltrate from Th1 to Th2 cells.
Diabetes April 1997 46:589-598; doi:10.2337/diabetes.46.4.589
- Abstract
Select this article
- L A O'Reilly,
- D Gu,
- N Sarvetnick,
- H Edlund,
- J M Phillips,
- T Fulford,
- and A Cooke
alpha-Cell neogenesis in an animal model of IDDM.
Diabetes April 1997 46:599-606; doi:10.2337/diabetes.46.4.599
- Abstract
Select this article
- A Kautzky-Willer,
- K Thomaseth,
- B Ludvik,
- P Nowotny,
- D Rabensteiner,
- W Waldhäusl,
- G Pacini,
- and R Prager
Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.
Diabetes April 1997 46:607-614; doi:10.2337/diabetes.46.4.607
- Abstract
Select this article
- W G Ding and
- J Gromada
Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide.
Diabetes April 1997 46:615-621; doi:10.2337/diabetes.46.4.615
- Abstract
Select this article
- P Dussoix,
- M Vaxillaire,
- P B Iynedjian,
- J M Tiercy,
- J Ruiz,
- G A Spinas,
- W Berger,
- G Zahnd,
- P Froguel,
- and J Philippe
Diagnostic heterogeneity of diabetes in lean young adults: classification based on immunological and genetic parameters.
Diabetes April 1997 46:622-631; doi:10.2337/diabetes.46.4.622
- Abstract
Select this article
- R G Thompson,
- J Peterson,
- A Gottlieb,
- and J Mullane
Effects of pramlintide, an analog of human amylin, on plasma glucose profiles in patients with IDDM: results of a multicenter trial.
Diabetes April 1997 46:632-636; doi:10.2337/diabetes.46.4.632
- Abstract
Select this article
- S R Myers,
- F E Yakubu-Madus,
- W T Johnson,
- J E Baker,
- T S Cusick,
- V K Williams,
- F C Tinsley,
- A Kriauciunas,
- J Manetta,
- and V J Chen
Acylation of human insulin with palmitic acid extends the time action of human insulin in diabetic dogs.
Diabetes April 1997 46:637-642; doi:10.2337/diabetes.46.4.637
- Abstract
Select this article
- E Cersosimo,
- P E Molina,
- and N N Abumrad
Renal glucose production during insulin-induced hypoglycemia.
Diabetes April 1997 46:643-646; doi:10.2337/diabetes.46.4.643
- Abstract
Select this article
- A P Mizisin,
- N A Calcutt,
- P S DiStefano,
- A Acheson,
- and F M Longo
Aldose reductase inhibition increases CNTF-like bioactivity and protein in sciatic nerves from galactose-fed and normal rats.
Diabetes April 1997 46:647-652; doi:10.2337/diabetes.46.4.647
- Abstract
Select this article
- L Schmetterer,
- O Findl,
- P Fasching,
- W Ferber,
- K Strenn,
- H Breiteneder,
- H Adam,
- H G Eichler,
- and M Wolzt
Nitric oxide and ocular blood flow in patients with IDDM.
Diabetes April 1997 46:653-658; doi:10.2337/diabetes.46.4.653
- Abstract
Select this article
- J Song,
- M F Walsh,
- R Igwe,
- J L Ram,
- M Barazi,
- L J Dominguez,
- and J R Sowers
Troglitazone reduces contraction by inhibition of vascular smooth muscle cell Ca2+ currents and not endothelial nitric oxide production.
Diabetes April 1997 46:659-664; doi:10.2337/diabetes.46.4.659
- Abstract
Select this article
- K Y Forrest,
- R E Maser,
- G Pambianco,
- D J Becker,
- and T J Orchard
Hypertension as a risk factor for diabetic neuropathy: a prospective study.
Diabetes April 1997 46:665-670; doi:10.2337/diabetes.46.4.665
- Abstract
Select this article
- P A Craven,
- R K Studer,
- J Felder,
- S Phillips,
- and F R DeRubertis
Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells.
Diabetes April 1997 46:671-681; doi:10.2337/diabetes.46.4.671
- Abstract
Select this article
- K Kogawa,
- Y Nishizawa,
- M Hosoi,
- T Kawagishi,
- K Maekawa,
- T Shoji,
- Y Okuno,
- and H Morii
Effect of polymorphism of apolipoprotein E and angiotensin-converting enzyme genes on arterial wall thickness.
Diabetes April 1997 46:682-687; doi:10.2337/diabetes.46.4.682
- Abstract
Select this article
- E H Hani,
- K Clément,
- G Velho,
- N Vionnet,
- J Hager,
- A Philippi,
- C Dina,
- H Inoue,
- M A Permutt,
- A Basdevant,
- M North,
- F Demenais,
- B Guy-Grand,
- and P Froguel
Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbid obesity among French Caucasians.
Diabetes April 1997 46:688-694; doi:10.2337/diabetes.46.4.688
- Abstract
Select this article
- P Denny,
- C J Lord,
- N J Hill,
- J V Goy,
- E R Levy,
- P L Podolin,
- L B Peterson,
- L S Wicker,
- J A Todd,
- and P A Lyons
Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene.
Diabetes April 1997 46:695-700; doi:10.2337/diabetes.46.4.695
- Abstract
Select this article
- S L Edelstein,
- W C Knowler,
- R P Bain,
- R Andres,
- E L Barrett-Connor,
- G K Dowse,
- S M Haffner,
- D J Pettitt,
- J D Sorkin,
- D C Muller,
- V R Collins,
- and R F Hamman
Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies.
Diabetes April 1997 46:701-710; doi:10.2337/diabetes.46.4.701
- Abstract
- J Rissanen,
- J Pihlajamäki,
- S Heikkinen,
- P Kekäläinen,
- J Kuusisto,
- and M Laakso
The Ala54Thr polymorphism of the fatty acid binding protein 2 gene does not influence insulin sensitivity in Finnish nondiabetic and NIDDM subjects.
Diabetes April 1997 46:711-712
Select this article
- J R Bilbao,
- B Calvo,
- I Urrutia,
- A Linares,
- and L Castaño
Anti-insulin activity in normal newborn cord-blood serum: absence of IgG-mediated insulin binding.
Diabetes April 1997 46:713-716; doi:10.2337/diabetes.46.4.713
- Abstract
Select this article
- K E Zakrzewska,
- I Cusin,
- A Sainsbury,
- F Rohner-Jeanrenaud,
- and B Jeanrenaud
Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance.
Diabetes April 1997 46:717-719; doi:10.2337/diabetes.46.4.717
- Abstract
Select this article
- T M Frayling,
- M P Bulamn,
- S Ellard,
- M Appleton,
- M J Dronsfield,
- A D Mackie,
- J D Baird,
- P J Kaisaki,
- K Yamagata,
- G I Bell,
- S C Bain,
- and A T Hattersley
Mutations in the hepatocyte nuclear factor-1alpha gene are a common cause of maturity-onset diabetes of the young in the U.K.
Diabetes April 1997 46:720-725; doi:10.2337/diabetes.46.4.720
- Abstract
Select this article
- T Hansen,
- H Eiberg,
- M Rouard,
- M Vaxillaire,
- A M Møller,
- S K Rasmussen,
- M Fridberg,
- S A Urhammer,
- J J Holst,
- K Almind,
- S M Echwald,
- L Hansen,
- G I Bell,
- and O Pedersen
Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation.
Diabetes April 1997 46:726-730; doi:10.2337/diabetes.46.4.726
- Abstract

New insights into the role and mechanism of glycogen synthase activation by insulin.

Bioavailability and bioeffectiveness of subcutaneous human insulin and two of its analogs--LysB28ProB29-human insulin and AspB10LysB28ProB29-human insulin--assessed in a conscious pig model.

Immunological aspects of nutritional diabetes prevention in NOD mice: a pilot study for the cow's milk-based IDDM prevention trial.

Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test.

Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice.

Glutamate decarboxylase-reactive peripheral blood lymphocytes from patients with IDDM express gut-specific homing receptor alpha4beta7-integrin.

Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats: dose, timing, early effect on islet area, and switch in infiltrate from Th1 to Th2 cells.

alpha-Cell neogenesis in an animal model of IDDM.

Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.

Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide.

Diagnostic heterogeneity of diabetes in lean young adults: classification based on immunological and genetic parameters.

Effects of pramlintide, an analog of human amylin, on plasma glucose profiles in patients with IDDM: results of a multicenter trial.

Acylation of human insulin with palmitic acid extends the time action of human insulin in diabetic dogs.

Renal glucose production during insulin-induced hypoglycemia.

Aldose reductase inhibition increases CNTF-like bioactivity and protein in sciatic nerves from galactose-fed and normal rats.

Nitric oxide and ocular blood flow in patients with IDDM.

Troglitazone reduces contraction by inhibition of vascular smooth muscle cell Ca2+ currents and not endothelial nitric oxide production.

Hypertension as a risk factor for diabetic neuropathy: a prospective study.

Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells.

Effect of polymorphism of apolipoprotein E and angiotensin-converting enzyme genes on arterial wall thickness.

Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbid obesity among French Caucasians.

Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene.

Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies.

The Ala54Thr polymorphism of the fatty acid binding protein 2 gene does not influence insulin sensitivity in Finnish nondiabetic and NIDDM subjects.

Anti-insulin activity in normal newborn cord-blood serum: absence of IgG-mediated insulin binding.

Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance.

Mutations in the hepatocyte nuclear factor-1alpha gene are a common cause of maturity-onset diabetes of the young in the U.K.

Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation.

This Issue

Current Issue